Scholarlink

<p>We assessed the risk factors of post-neonatal anti-epileptic medications after neonatal intensive care unit discharge (PD-AED) and neurodevelopmental (ND) outcomes by age three in very-low-birth-weight infants (VLBWIs), with 7,292 VLBWIs born in 2013–2020 using the Korean Neonatal Network data. We assessed the risk factor of PD-AED and compared the risks for cerebral palsy (CP), blindness, deafness, and ND impairments between five groups: group 1, no seizure; group 2, neonatal seizure only; group 3, neonatal seizure + PD-AED before age three; group 4, neonatal seizure + PD-AED up to age three; group 5, PD-AED without neonatal seizure. By age three, 515 infants (7.1%) had seizures and 241 infants (3.8%) had PD-AED. Higher GA, intra-ventricular hemorrhage ≥ grade 3, post-hemorrhagic hydrocephalus, neonatal seizures, cystic periventricular leukomalacia, necrotizing enterocolitis ≥ stage 2, and moderate to severe bronchopulmonary dysplasia increased the risk of PD-AED. Compared to other groups, group 1 had the lowest risk of CP, while group 4 had the highest. The risk of hearing loss was higher in group 4 compared to groups 1, 2, and 5. Seizures at any time point increased the risk of CP. In infants with neonatal seizures, longer time on anti-epileptic medications also increased the CP risk.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Risk factors and neurodevelopmental outcomes of post-neonatal seizures up to age three in very-low-birthweight infants based on a nationwide cohort

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月19日

查看全文
  • Haemin Kang,
  • Jieun Jeong,
  • Sohee Oh,
  • Jin A Lee

摘要

We assessed the risk factors of post-neonatal anti-epileptic medications after neonatal intensive care unit discharge (PD-AED) and neurodevelopmental (ND) outcomes by age three in very-low-birth-weight infants (VLBWIs), with 7,292 VLBWIs born in 2013–2020 using the Korean Neonatal Network data. We assessed the risk factor of PD-AED and compared the risks for cerebral palsy (CP), blindness, deafness, and ND impairments between five groups: group 1, no seizure; group 2, neonatal seizure only; group 3, neonatal seizure + PD-AED before age three; group 4, neonatal seizure + PD-AED up to age three; group 5, PD-AED without neonatal seizure. By age three, 515 infants (7.1%) had seizures and 241 infants (3.8%) had PD-AED. Higher GA, intra-ventricular hemorrhage ≥ grade 3, post-hemorrhagic hydrocephalus, neonatal seizures, cystic periventricular leukomalacia, necrotizing enterocolitis ≥ stage 2, and moderate to severe bronchopulmonary dysplasia increased the risk of PD-AED. Compared to other groups, group 1 had the lowest risk of CP, while group 4 had the highest. The risk of hearing loss was higher in group 4 compared to groups 1, 2, and 5. Seizures at any time point increased the risk of CP. In infants with neonatal seizures, longer time on anti-epileptic medications also increased the CP risk.